The Beauty Health Company (SKIN)

Market Cap	112.57M -25.1%
Revenue (ttm)	300.79M -10.0%
Net Income	-9.52M
EPS	-0.16
Shares Out	127.77M
PE Ratio	n/a
Forward PE	36.91
Dividend	n/a
Ex-Dividend Date	n/a

Volume	757,785
Open	0.8969
Previous Close	0.8833
Day's Range	0.8400 - 0.9063
52-Week Range	0.7573 - 2.6900
Beta	1.24
Analysts	Buy
Price Target	2.03 (+130.42%)
Earnings Date	May 7, 2026

About SKIN

The Beauty Health Company, a global medical aesthetics company delivering an integrated ecosystem of clinically proven solutions in the Americas, the Asia-Pacific, Europe, the Middle East, Africa, Canada, and Latin America. The company’s flagship product is HydraFacial, which enhances the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. It also offers Syndeo devices, which are delivery systems that are designed to connect providers to the consumer’s preferences to create a more personalized experience; consu...

• Industry: Household & Personal Products
• Sector: Consumer Staples
• Founded: 1997
• Employees: 613
• Stock Exchange: NASDAQ
• Ticker Symbol: SKIN
• Website: https://www.beautyhealth.com

Financial Performance

In 2025, The Beauty Health Company's revenue was $300.79 million, a decrease of -10.02% compared to the previous year's $334.29 million. Losses were -$9.52 million, -67.29% less than in 2024.

Analyst Summary

According to 4 analysts, the average rating for SKIN stock is "Buy." The 12-month stock price target is $2.03, which is an increase of 130.42% from the latest price.

Price Target

$2.03

(130.42% upside)

Analyst Consensus: Buy